Continuous Glucose Monitoring (CGM) Devices Market

The global continuous glucose monitoring (CGM) devices market is expected to grow significantly from USD 529 million in 2018 to USD 1,263 million in 2025, at a CAGR of 12.4% from 2019 to 2025. The growth in the market is attributed to the increasing prevalence of diabetes across the globe, and growing awareness among people. In addition, increasing adoption of CGM devices is further propelling the market growth. However, higher cost than conventional glucose monitoring, and accuracy issues associated with CGM devices may restrain the market growth to some extent.

Continues glucose monitoring devices is sensor technology that enables the testing of glucose levels without pricking finger. CGM devices provide glucose level anytime at a glance. Small reusable transmitters connected to the sensor wire provide the real-time readings wirelessly to a receiver.

Key findings from the report:

• On the basis of component,
  • The transmitters & receivers segment held the major share of the market in 2018
  • The insulin pumps segment is expected to witness highest CAGR during the 2019-2025
• Based on end-user, the homecare settings segment held major share of the market in 2018
• Geographically, North America held the major share of the global market in 2018. Asia-Pacific is expected to witness the highest CAGR during the 2019-2025
• Some of the key companies operating in the market include Abbott Laboratories; Animas Corporation; Pfizer Inc.; DexCom, Inc.; Baxter International Inc.; Echo Therapeutics, Inc.; Medtronic PLC; F. Hoffmann-La Roche Ltd.; Novo Nordisk A/S; and Insulet Corporation; among others

Continuous glucose monitoring (CGM) devices revolutionizing glucose monitoring

More than 400 million people across the globe live with diabetes. Emerging innovative technologies have revolutionized the management & treatment of diabetes. The introduction of new glucose monitoring techniques and data analysis denotes an important opportunity for both patients and healthcare professionals. Moreover, various key players are focusing on delivering high-quality products and expanding their user base. Also, improvement in the technology and data sharing is projected to impel the demand over the forecast period.

Browse full research report with TOC on

To purchase report: [email protected]

Continuous Glucose Monitoring (CGM) Devices Market – Regional insight

Geographically, North America held the largest share of the market in 2018. The growth in the region is attributed to the increasing adoption of CGM. Moreover, increasing prevalence of diabetes and growing awareness among people regarding the benefits of CGM devices is further boosting the market growth in the region. The growth of continuous glucose monitoring (CGM) devices market in Europe is primarily due to the high penetration of smartphones, and increasing number of diabetic patients in the region.

This report segments global continuous glucose monitoring (CGM) devices market based oncomponent, age group, distribution channel, end-user and region.

By Component

• Sensors
• Transmitters & Receivers
• Insulin Pumps

By Age Group

• Children
• Adult

By Distribution Channel

• Online Pharmacies
• Retail Pharmacies

By End-user

• Clinics
• Hospitals
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Central & South America
• Middle East and Africa (MEA)

Global Continuous Glucose Monitoring Devices Market to Witness a CAGR of 12.4% during 2019-2025